Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) announced a boardroom reshuffle that includes the addition of two new members and the departure of four.
Robert Raich and Charles Bisaillon have joined as directors, bringing with them significant senior-level experience.
Raich served as senior partner for 25 years at Montreal's Spiegel Sohmer Inc., where he specialized in taxation law.
Bisaillon, an entrepreneur with a track record for rapidly scaling businesses, is currently the President and owner of Airtek Ltée, a Canadian manufacturing company, and also serves as the chief financial Oofficer for Groupe JB, a construction business.
Departing from the Valeo board are Michel Trudeau, Stuart Fowler, Didier Leconte, and Tamara Close, who have resigned from their positions.
"We are pleased to welcome Robert and Charles to the Valeo board of directors. They both bring many years of entrepreneurial spirit and experience, and we look forward to benefiting from their valuable insight and perspective", said Richard MacKay, Valeo's chairman.
"We would also like to thank Michel, Stuart, Didier, and Tamara for their contribution and guidance to our board of directors".
Valeo specializes in the commercialization of innovative prescription products within Canada, focusing on respiratory/allergy, ophthalmology, and hospital specialty products.